Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A14907 | 29179679 | BMC Gastroenterol | Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift. | 2017 | Details |
| A14909 | 29177681 | J Gastroenterol | Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods. | 2017 | Details |
| A14910 | 29177105 | J Clin Cell Immunol | Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis. | 2017 | Details |
| A14912 | 29175671 | J Nutr Biochem | Dietary omega-3 and omega-6 polyunsaturated fatty acids modulate hepatic pathology. | 2017 | Details |
| A14914 | 29175651 | Atherosclerosis | Subclinical cerebrovascular disease in NAFLD without overt risk factors for atherosclerosis. | 2017 | Details |
| A14916 | 29175242 | J Hepatol | Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients. | 2017 | Details |
| A14920 | 29174039 | Biomed Pharmacother | Lavatera critica, a green leafy vegetable, controls high fat diet induced hepatic lipid accumulation and oxidative stress through the regulation of lipogenesis and lipolysis genes. | 2017 | Details |
| A14921 | 29173646 | Nutr Res | Schisandra chinensis berry extract protects against steatosis by inhibiting histone acetylation in oleic acid-treated HepG2 cells and in the livers of diet-induced obese mice. | 2017 | Details |
| A14924 | 29171144 | Liver Int | Altered fatty acid-binding protein 4 (FABP4) expression and function in human and animal models of hepatocellular carcinoma. | 2017 | Details |
| A14925 | 29170905 | Endocrine | Irisin in metabolic diseases. | 2017 | Details |
| A14931 | 29167659 | Front Microbiol | Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota. | 2017 | Details |
| A14942 | 29163785 | Oncotarget | TM5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease. | 2017 | Details |
| A14944 | 29162773 | J Atheroscler Thromb | A High-Fat and High-Cholesterol Diet Induces Cardiac Fibrosis, Vascular Endothelial, and Left Ventricular Diastolic Dysfunction in SHRSP5/Dmcr Rats. | 2017 | Details |
| A14945 | 29162389 | J Hepatol | Is cryptogenic cirrhosis different from NASH cirrhosis? | 2017 | Details |
| A14946 | 29161258 | PLoS One | Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS. | 2017 | Details |
| A14947 | 29161233 | J Basic Clin Physiol Pharmacol | Swimming, but not vitamin E, ameliorates prothrombotic state and hypofibrinolysis in a rat model of nonalcoholic fatty liver disease. | 2018 | Details |
| A14948 | 29160087 | Antioxid Redox Signal | Glyoxalase 1 Modulation in Obesity and Diabetes. | 2018 | Details |
| A14952 | 29158770 | Nutr Metab (Lond) | Does the enterolactone (ENL) affect fatty acid transporters and lipid metabolism in liver? | 2017 | Details |
| A14954 | 29158157 | Clin Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men. | 2017 | Details |
| A14960 | 29155143 | Eur J Pharmacol | Obeticholic acid raises LDL-cholesterol and reduces HDL-cholesterol in the Diet-Induced NASH (DIN) hamster model. | 2017 | Details |
| A14965 | 29152605 | Hepatol Commun | Hepatic Natural Killer T-cell and CD8+ T-cell Signatures in Mice with Nonalcoholic Steatohepatitis. | 2017 | Details |
| A14973 | 29150490 | Gut | Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. | 2017 | Details |
| A14985 | 29139555 | Br J Pharmacol | Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease. | 2018 | Details |
| A14986 | 29138984 | Curr Hypertens Rep | 11β-Hydroxysteroid Dehydrogenases and Hypertension in the Metabolic Syndrome. | 2017 | Details |
| A14992 | 29133512 | Diabetes | Exosomes From Adipose-Derived Stem Cells Attenuate Adipose Inflammation and Obesity Through Polarizing M2 Macrophages and Beiging in White Adipose Tissue. | 2017 | Details |
| A15004 | 29128158 | Trends Endocrinol Metab | Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism. | 2017 | Details |
| A15008 | 29128061 | Clin Liver Dis | The Genetics of Pediatric Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15009 | 29128060 | Clin Liver Dis | Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics. | 2017 | Details |
| A15011 | 29128058 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation. | 2017 | Details |
| A15012 | 29128057 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma. | 2018 | Details |
| A15016 | 29128053 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease and Metabolic Syndrome. | 2017 | Details |
| A15017 | 29128052 | Clin Liver Dis | The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A15018 | 29128051 | Clin Liver Dis | The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View. | 2018 | Details |
| A15023 | 29126873 | Mol Metab | Dual role of protein tyrosine phosphatase 1B in the progression and reversion of non-alcoholic steatohepatitis. | 2017 | Details |
| A15024 | 29126863 | Surg Obes Relat Dis | Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients. | 2017 | Details |
| A15029 | 29124703 | Adv Exp Med Biol | Vitamin D, Cardiovascular Disease and Risk Factors. | 2017 | Details |
| A15034 | 29122695 | J Hepatol | Should we undertake surveillance for HCC in patients with NAFLD? | 2017 | Details |
| A15035 | 29122694 | J Hepatol | Pharmacotherapy for NASH: Current and emerging. | 2017 | Details |
| A15037 | 29122442 | Nutr Metab Cardiovasc Dis | Serum Fetuin-A levels in obese children with biopsy proven nonalcoholic fatty liver disease. | 2017 | Details |
| A15040 | 29122389 | J Hepatol | The nutritional geometry of liver disease including non-alcoholic fatty liver disease. | 2017 | Details |
| A15041 | 29121861 | BMC Genomics | Transcriptomics, metabolomics and histology indicate that high-carbohydrate diet negatively affects the liver health of blunt snout bream (Megalobrama amblycephala). | 2017 | Details |
| A15043 | 29120742 | Cell Host Microbe | The Human Microbiome and Obesity: Moving beyond Associations. | 2017 | Details |
| A15044 | 29119725 | Obes Rev | Systematic review and meta-analysis: non-invasive detection of non-alcoholic fatty liver disease related fibrosis in the obese. | 2017 | Details |
| A15047 | 29119336 | Obes Surg | Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study. | 2018 | Details |
| A15049 | 29118867 | Gastroenterology Res | Non-Alcoholic Fatty Liver Disease in Africa and Middle East: An Attempt to Predict the Present and Future Implications on the Healthcare System. | 2017 | Details |
| A15051 | 29118561 | Ann Gastroenterol | Pilot study of the prevalence of binge eating disorder in non-alcoholic fatty liver disease patients. | 2017 | Details |
| A15058 | 29115682 | Aliment Pharmacol Ther | Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration. | 2017 | Details |
| A15060 | 29114108 | Acta Inform Med | Therapeutic Effects of Curcumin on Ultrasonic Morphological Characteristics of Liver in Patients with Metabolic Syndrome. | 2017 | Details |
| A15061 | 29113910 | J Hepatol | The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease. | 2017 | Details |
| A15063 | 29113510 | Diab Vasc Dis Res | Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases. | 2017 | Details |
| A15064 | 29113135 | Nutrients | Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15065 | 29113028 | Hepatology | Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis. | 2018 | Details |
| A15071 | 29109303 | Clin Sci (Lond) | Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD? | 2017 | Details |
| A15072 | 29108214 | Zhonghua Gan Zang Bing Za Zhi | [Association between intestinal flora imbalance and nonalcoholic fatty liver disease]. | 2017 | Details |
| A15073 | 29108205 | Zhonghua Gan Zang Bing Za Zhi | [Investigation and analysis of the knowledge of nonalcoholic fatty liver disease among residents in Hebei Province, China]. | 2017 | Details |
| A15078 | 29107284 | Mol Metab | Superior reductions in hepatic steatosis and fibrosis with co-administration of a glucagon-like peptide-1 receptor agonist and obeticholic acid in mice. | 2017 | Details |
| A15079 | 29106945 | Metabolism | Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease. | 2017 | Details |
| A15081 | 29106384 | J Clin Invest | Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression. | 2017 | Details |
| A15083 | 29104811 | Liver Res | Bile acid metabolism and signaling in liver disease and therapy. | 2017 | Details |
| A15085 | 29104232 | Antioxidants (Basel) | Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes. | 2017 | Details |
| A15086 | 29104128 | Clin Gastroenterol Hepatol | Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver Disease. | 2018 | Details |
| A15087 | 29104004 | Surg Obes Relat Dis | Nonalcoholic fatty liver disease in patients with different baseline glucose status undergoing bariatric surgery: analysis of intraoperative liver biopsies and literature review. | 2017 | Details |
| A15090 | 29101772 | Rom J Intern Med | Liver disease symptoms in non-alcoholic fatty liver disease and small intestinal bacterial overgrowth. | 2018 | Details |
| A15091 | 29101357 | Sci Rep | MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1. | 2017 | Details |
| A15092 | 29100781 | Steroids | Estrogens and female liver health. | 2017 | Details |
| A15094 | 29099463 | J Clin Gastroenterol | Associations of Insulin Resistance and Glycemia With Liver Enzymes in Hispanic/Latino Youths: Results From the Hispanic Community Children's Health Study/Study of Latino Youth (SOL Youth). | 2019 | Details |
| A15095 | 29098545 | Obes Surg | Non-alcoholic Fatty Liver Disease in Morbidly Obese Individuals Undergoing Bariatric Surgery: Prevalence and Effect of the Pre-Bariatric Very Low Calorie Diet. | 2018 | Details |
| A15104 | 29092796 | Mol Metab | AMPK activation caused by reduced liver lactate metabolism protects against hepatic steatosis in MCT1 haploinsufficient mice. | 2017 | Details |
| A15109 | 29090431 | J Endocrinol Invest | Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients. | 2017 | Details |
| A15112 | 29089335 | Am J Physiol Endocrinol Metab | Effects of periconceptional maternal alcohol intake and a postnatal high-fat diet on obesity and liver disease in male and female rat offspring. | 2017 | Details |
| A15116 | 29086488 | J Diabetes Investig | Molecular mechanism of obesity-induced 'metabolic' tissue remodeling. | 2017 | Details |
| A15121 | 29085434 | Evid Based Complement Alternat Med | Effect of Seyoeum on Obesity, Insulin Resistance, and Nonalcoholic Fatty Liver Disease of High-Fat Diet-Fed C57BL/6 Mice. | 2017 | Details |
| A15125 | 29084519 | BMC Public Health | Waist-to-height ratio is a useful index for nonalcoholic fatty liver disease in children and adolescents: a secondary data analysis. | 2017 | Details |
| A15131 | 29083036 | Aliment Pharmacol Ther | Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease. | 2017 | Details |
| A15134 | 29080393 | Rom J Intern Med | Lipid profile pattern in pediatric overweight population with or without NAFLD in relation to IDF criteria for metabolic syndrome: a preliminary study. | 2018 | Details |
| A15136 | 29080046 | Curr Gastroenterol Rep | The Microbiome That Shapes Us: Can It Cause Obesity? | 2017 | Details |
| A15138 | 29077769 | PLoS One | The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter. | 2017 | Details |
| A15146 | 29074725 | Gut | Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice. | 2017 | Details |
| A15147 | 29074597 | Diabetes | S-Nitrosoglutathione Reductase Dysfunction Contributes to Obesity-Associated Hepatic Insulin Resistance via Regulating Autophagy. | 2017 | Details |
| A15151 | 29073114 | Proc Natl Acad Sci U S A | Pathogenesis of hypothyroidism-induced NAFLD is driven by intra- and extrahepatic mechanisms. | 2017 | Details |
| A15159 | 29067150 | Frontline Gastroenterol | Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey. | 2017 | Details |
| A15167 | 29065507 | Nutrients | Fatty Acids Consumption: The Role Metabolic Aspects Involved in Obesity and Its Associated Disorders. | 2017 | Details |
| A15168 | 29065499 | Diseases | An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15169 | 29065431 | Horm Metab Res | Liver Fat Content in People with Pituitary Diseases: Influence of Serum IGF1 Levels. | 2017 | Details |
| A15170 | 29065180 | PLoS One | Hepcidin in morbidly obese women with non-alcoholic fatty liver disease. | 2017 | Details |
| A15174 | 29063908 | Am J Gastroenterol | Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance. | 2017 | Details |
| A15175 | 29063416 | Dig Dis Sci | Nonalcoholic Fatty Liver Disease Is Associated with Increased Risk of Reflux Esophagitis. | 2017 | Details |
| A15176 | 29063072 | Chronic Dis Transl Med | Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease. | 2017 | Details |
| A15177 | 29062902 | Clin Exp Hepatol | The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease. | 2017 | Details |
| A15182 | 29059456 | Hepatology | Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science. | 2018 | Details |
| A15184 | 29058997 | Annu Rev Pharmacol Toxicol | Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging Therapies. | 2017 | Details |
| A15189 | 29056532 | Mol Cell Endocrinol | LAMP3 regulates hepatic lipid metabolism through activating PI3K/Akt pathway. | 2017 | Details |
| A15193 | 29056000 | Zhonghua Gan Zang Bing Za Zhi | [The progress of studying the mechanisms of immune cells in the regulation of non-alcoholic fatty liver diseases]. | 2017 | Details |
| A15195 | 29055928 | Ann Hepatol | New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation. | 2018 | Details |
| A15199 | 29055914 | Ann Hepatol | Evidence-Based Medicine and the Problem of Healthy Volunteers. | 2018 | Details |
| A15201 | 29055669 | Surg Obes Relat Dis | Impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004-2012. | 2017 | Details |
| A15204 | 29051770 | Nutr Metab (Lond) | Serum alanine aminotransferase/aspartate aminotransferase ratio is one of the best markers of insulin resistance in the Chinese population. | 2017 | Details |
| A15206 | 29049401 | PLoS One | Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare. | 2017 | Details |
| A15213 | 29043609 | Curr HIV/AIDS Rep | The Fat of the Matter: Obesity and Visceral Adiposity in Treated HIV Infection. | 2017 | Details |
| A15217 | 29040439 | Carcinogenesis | Eicosapentaenoic acid attenuates obesity-related hepatocellular carcinogenesis. | 2018 | Details |